ACTEMRA® (TOCILIZUMAB) is not approved by the FDA for the treatment of hospitalized children with severe COVID-19 pneumonia.

Click here for more information on approved uses of Actemra.

Side Effect Reporting

You may report side effects to the FDA at (800) FDA-1088 or
You may also report side effects to Genentech at (888) 835-2555.